Inactivated vaccine against Aujeszky's disease

Background and Aim: The Aujeszky's disease, also known as Pseudorabies, remains one of the most problematic fulminant diseases in domestic animals, affecting the central nervous system. The study aimed to investigate the effect of an inactivated vaccine against Aujeszky's disease based on...

Full description

Bibliographic Details
Main Authors: Zhanat B. Kondibaeva, Bolat A. Yespembetov, Khairulla B. Abeuov, Assiya K. Mussayeva, Sarsenbek T. Siyabekov, Saltanat T. Nussupova, Elmira K. Akmatova, Yerlan K. Pazylov, Kydyrbay T. Maikhin, Nazym S. Syrym
Format: Article
Language:English
Published: Veterinary World 2021-11-01
Series:Veterinary World
Subjects:
Online Access:http://www.veterinaryworld.org/Vol.14/November-2021/16.pdf
_version_ 1818567343471591424
author Zhanat B. Kondibaeva
Bolat A. Yespembetov
Khairulla B. Abeuov
Assiya K. Mussayeva
Sarsenbek T. Siyabekov
Saltanat T. Nussupova
Elmira K. Akmatova
Yerlan K. Pazylov
Kydyrbay T. Maikhin
Nazym S. Syrym
author_facet Zhanat B. Kondibaeva
Bolat A. Yespembetov
Khairulla B. Abeuov
Assiya K. Mussayeva
Sarsenbek T. Siyabekov
Saltanat T. Nussupova
Elmira K. Akmatova
Yerlan K. Pazylov
Kydyrbay T. Maikhin
Nazym S. Syrym
author_sort Zhanat B. Kondibaeva
collection DOAJ
description Background and Aim: The Aujeszky's disease, also known as Pseudorabies, remains one of the most problematic fulminant diseases in domestic animals, affecting the central nervous system. The study aimed to investigate the effect of an inactivated vaccine against Aujeszky's disease based on "Kordai" virus strain. Materials and Methods: To test the inactivation of the "Kordai" strain (grown by the roller method in VNK-21/13 cell culture with an infectious titer of at least 7.5 lg TCD50/ml) which is causative of Aujeszky's disease, next-generation teotropin and propolis preparations were used in concentrations of 0.1%, 0.08%, and 0.04%. Results: As a result of comparative studies on the optimization of parameters for inactivating the "Kordai" virus strain, it was established that teotropin is a more effective inactivant than propolis. At the same time, the optimal final concentration of teotropin for inactivation was 0.1%, along with a reaction medium temperature of 37°C, pH of 7.4-7.6, and duration of inactivation of 14 h. The titer of virus-neutralizing activity (VNA) of antibodies at the pH (neutralization reactions) in vaccinated sheep of 10-12 months of age was 7.5±0.3, Ig TCID50/ml (tissue culture infectious dose 50%), and 3.5±0.3 in the cell culture VNK-21/13 (culture of Syrian hamster kidney cells). Conclusion: To determine colostral immunity in newborn lambs, the method of metabolic status correction was used to vaccinate lambs obtained from immune sheep 4 months after birth. The results showed that lambs obtained from immune sheep had high VNA titers. A sustained immune response in vaccinated animals was obtained after double vaccination.
first_indexed 2024-12-14T06:22:10Z
format Article
id doaj.art-d44e9a47b5f849f1ac97587bc5aa32bf
institution Directory Open Access Journal
issn 0972-8988
2231-0916
language English
last_indexed 2024-12-14T06:22:10Z
publishDate 2021-11-01
publisher Veterinary World
record_format Article
series Veterinary World
spelling doaj.art-d44e9a47b5f849f1ac97587bc5aa32bf2022-12-21T23:13:47ZengVeterinary WorldVeterinary World0972-89882231-09162021-11-0114112957296310.14202/vetworld.2021.2957-2963Inactivated vaccine against Aujeszky's diseaseZhanat B. Kondibaeva0https://orcid.org/0000-0002-2959-1161Bolat A. Yespembetov1https://orcid.org/0000-0002-9116-6836Khairulla B. Abeuov2https://orcid.org/0000-0002-6925-9315Assiya K. Mussayeva3https://orcid.org/0000-0001-5476-4207Sarsenbek T. Siyabekov4https://orcid.org/0000-0002-2266-6351Saltanat T. Nussupova5https://orcid.org/0000-0002-9553-0666Elmira K. Akmatova6https://orcid.org/0000-0002-2805-8701Yerlan K. Pazylov7https://orcid.org/0000-0001-6500-668XKydyrbay T. Maikhin8https://orcid.org/0000-0003-1744-2860Nazym S. Syrym9https://orcid.org/0000-0002-7313-0899Laboratory of Diagnostic of the Infectious Diseases , Research Institute for Biological Safety Problems, Gwardeiski, Kazakhstan.Laboratory of Microbiology , Research Institute for Biological Safety Problems, Gwardeiski, Kazakhstan.Laboratory of Diagnostic of the Infectious Diseases , Research Institute for Biological Safety Problems, Gwardeiski, Kazakhstan.Bacteriology Laboratory , Kazakh Scientific Research Veterinary Institute, Astana, Kazakhstan.Department of Clinical Veterinary Medicine , Kazakh National Agrarian University, Almaty, Kazakhstan.Department of Clinical Veterinary Medicine , Kazakh National Agrarian University, Almaty, Kazakhstan.Laboratory o the diseases of domestic animals, Kyrgyz Research Institute of Veterinary named after A. Duysheev, Bishkek, Kyrgyzstan.Laboratory of Diagnosis of Infectious Diseases, National Reference Veterinary Center Almaty Branch, Almaty, Kazakhstan.Laboratory of Diagnosis of Infectious Diseases, National Reference Veterinary Center Almaty Branch, Almaty, Kazakhstan.Laboratory of Microbiology , Research Institute for Biological Safety Problems, Gwardeiski, Kazakhstan.Background and Aim: The Aujeszky's disease, also known as Pseudorabies, remains one of the most problematic fulminant diseases in domestic animals, affecting the central nervous system. The study aimed to investigate the effect of an inactivated vaccine against Aujeszky's disease based on "Kordai" virus strain. Materials and Methods: To test the inactivation of the "Kordai" strain (grown by the roller method in VNK-21/13 cell culture with an infectious titer of at least 7.5 lg TCD50/ml) which is causative of Aujeszky's disease, next-generation teotropin and propolis preparations were used in concentrations of 0.1%, 0.08%, and 0.04%. Results: As a result of comparative studies on the optimization of parameters for inactivating the "Kordai" virus strain, it was established that teotropin is a more effective inactivant than propolis. At the same time, the optimal final concentration of teotropin for inactivation was 0.1%, along with a reaction medium temperature of 37°C, pH of 7.4-7.6, and duration of inactivation of 14 h. The titer of virus-neutralizing activity (VNA) of antibodies at the pH (neutralization reactions) in vaccinated sheep of 10-12 months of age was 7.5±0.3, Ig TCID50/ml (tissue culture infectious dose 50%), and 3.5±0.3 in the cell culture VNK-21/13 (culture of Syrian hamster kidney cells). Conclusion: To determine colostral immunity in newborn lambs, the method of metabolic status correction was used to vaccinate lambs obtained from immune sheep 4 months after birth. The results showed that lambs obtained from immune sheep had high VNA titers. A sustained immune response in vaccinated animals was obtained after double vaccination.http://www.veterinaryworld.org/Vol.14/November-2021/16.pdfadjuvantaujeszky's disease viruscolostral immunityimmunogenicitystrain "kordai"
spellingShingle Zhanat B. Kondibaeva
Bolat A. Yespembetov
Khairulla B. Abeuov
Assiya K. Mussayeva
Sarsenbek T. Siyabekov
Saltanat T. Nussupova
Elmira K. Akmatova
Yerlan K. Pazylov
Kydyrbay T. Maikhin
Nazym S. Syrym
Inactivated vaccine against Aujeszky's disease
Veterinary World
adjuvant
aujeszky's disease virus
colostral immunity
immunogenicity
strain "kordai"
title Inactivated vaccine against Aujeszky's disease
title_full Inactivated vaccine against Aujeszky's disease
title_fullStr Inactivated vaccine against Aujeszky's disease
title_full_unstemmed Inactivated vaccine against Aujeszky's disease
title_short Inactivated vaccine against Aujeszky's disease
title_sort inactivated vaccine against aujeszky s disease
topic adjuvant
aujeszky's disease virus
colostral immunity
immunogenicity
strain "kordai"
url http://www.veterinaryworld.org/Vol.14/November-2021/16.pdf
work_keys_str_mv AT zhanatbkondibaeva inactivatedvaccineagainstaujeszkysdisease
AT bolatayespembetov inactivatedvaccineagainstaujeszkysdisease
AT khairullababeuov inactivatedvaccineagainstaujeszkysdisease
AT assiyakmussayeva inactivatedvaccineagainstaujeszkysdisease
AT sarsenbektsiyabekov inactivatedvaccineagainstaujeszkysdisease
AT saltanattnussupova inactivatedvaccineagainstaujeszkysdisease
AT elmirakakmatova inactivatedvaccineagainstaujeszkysdisease
AT yerlankpazylov inactivatedvaccineagainstaujeszkysdisease
AT kydyrbaytmaikhin inactivatedvaccineagainstaujeszkysdisease
AT nazymssyrym inactivatedvaccineagainstaujeszkysdisease